StreetAlpha.app
Home › Stocks › ELV

Elevance Health, Inc. (ELV)

Healthcare
$434.05
▼ −2.82%
LAST CLOSE · NOV 17

Elevance Health is a health insurer based in Indianapolis that sells health plans to individuals, employers and government programs. It last closed at $434.05 on Nov 17, down 2.82% on the day. ELV reports earnings on Wed, Jan 27, 2027. The average 12-month price target from 7 analysts is $469.29 (+8.1% from the last close), with a high of $523.00 and a low of $406.00. Analyst consensus is Buy, based on the latest ratings from 7 firms (4 buy, 3 hold, 0 sell). Over the past 90 days StreetAlpha recorded 7 whale options trades in ELV, 57% of them bullish and 43% bearish. In the past 30 days there were 7 dark pool prints totaling $7.7M, the largest $2.2M.

AI Auto Pilots
Is ELV in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$202B
+3.6% vs a year ago
Net income
$5.1B
−7.1% vs a year ago
EPS (diluted)
$23.55
−4.0% vs a year ago
Free cash flow
$6.5B
3.2% margin
Valuation
Market cap
$93.8B
216.1M shares
P/E
18.4
Price over 12 month EPS
Price to sales
0.5
Market cap over revenue
Dividend yield
1.58%
$6.87 a share over 12 months
Balance sheet
Cash & equivalents
$10.3B
At Sep 30
Debt
$30.8B
At Sep 30
Shareholder equity
$44.7B
Buybacks
$2.2B
Last 12 months
CEOGail Boudreaux
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $139B$139BFY2021FY2022: $157B$157BFY2022FY2023: $171B$171BFY2023FY2024: $177B$177BFY2024FY2025: $199B$199BFY2025

From ELV's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 21). Last 12 months adds up the four latest quarters.

Next report
Jan 27
2027 · Time not announced
Consensus EPS forecast
$2.08
$49.38B revenue est.
Year-ago EPS
$3.33
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
Buy
Based on 7 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
7firms
4 Buy3 Hold0 Sell
Each firm's latest rating on ELV in the past 90 days
Average 12-month target
$469.29
▲ 8.1% upside

Based on 7 analysts who set a price target on ELV in the past 90 days. The average target is $469.29, with a high of $523.00 and a low of $406.00, compared with the last close of $434.05.

Low $406.00Avg $469.29High $523.00
Blue marker: last close $434.05
Highest target$523.00
Average target$469.29
Lowest target$406.00
Latest rating changes
TD CowenTarget raised
Oct 23Buy$465 → $495
UBSTarget raised
Oct 22Buy$460 → $523
GuggenheimTarget raised
Oct 22Buy$460 → $485
Morgan StanleyTarget raised
Oct 22Hold$404 → $449
RBC CapitalTarget raised
Oct 22Hold$424 → $455
DateFirmActionRatingPrice target
Oct 23TD CowenTarget raisedBuy$465 → $495
Oct 22UBSTarget raisedBuy$460 → $523
Oct 22GuggenheimTarget raisedBuy$460 → $485
Oct 22Morgan StanleyTarget raisedHold$404 → $449
Oct 22RBC CapitalTarget raisedHold$424 → $455
Loading…

Technical Analysis

ELV · as of the Nov 17 close · updated after every close
Uptrend

The stock is 1% above its 20 day and 4% above its 50 day average. It is 13% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 55). The nearest support is the Pivot S1 at $430.40, and the nearest resistance the Pivot at $435.27.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityNormal, 2.9%/day
Key levels
$450.6952 week high+3.8%
$438.92Pivot R1+1.1%
$436.24Swing high (Jul 14)+0.5%
$435.27Pivot+0.3%
$434.05Last close
$430.40Pivot S1−0.8%
$428.3120 day average−1.3%
$416.8450 day average−4.0%
$406.90Swing low (Nov 2)−6.3%
$406.63100 day average−6.3%
$376.47200 day average−13.3%
$274.8452 week low−36.7%
Indicators
RSI (14)55.10Middle of its rangeNeutral
MACD4.88Above its signal lineBullish
Stochastic71.8Middle of its rangeNeutral
ADX (14)18.7No clear trend
Williams %R-34.8Oversold below −80, overbought above −20Neutral
CCI (20)62.2Oversold below −100, overbought above 100Neutral
Rate of change+4.9%Change over 10 sessionsBullish
ATR (14)$12.79Typical daily range, 3.0% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for ELV

What happened before

See how ELV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow is mixed4 bullish and 3 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow ELV usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ELV has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
7
Bullish
4
57%
Bearish
3
43%
Date span
Oct 13 – Oct 21
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
7
Notional
$7.7M
Largest print
$2.2M
Loading…

ELV Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ●759 buying vs 691 selling
  • ▼Held by funds -5.3 pts
  • ●Funds holding +1
  • ▼Superinvestors: 1 added, 2 cut
  • ▼Put/call 1.00 to 1.11
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1,6151,614+0.1%
In funds' top 102127−22.2%
Held by funds89.3%94.7%−5.3 pts
New / increased152 / 607245 / 591−9.2%
Reduced / sold out559 / 132543 / 105+6.6%
Put/call ratio1.111.00+10.7%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ELV institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

ELV Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$2.2B
2.3% yield
Left in program
$5.0B
5.3% of value
Shares outstanding, 12 months
−2.8%
Fewer shares
Last quarter
$330.8M
Sep 2026
Avg price paid, last quarter
$398.76
830K shares bought
S&P 500 rank by spending
#100 of 358
 
Spent each quarter, last 3 yearsTop bar $1.8B
Dec 2023: $930.5M, average price $465.64Mar 2024: $666.6M, average price $493.77Jun 2024: $464.6M, average price $524.58Sep 2024: $63.4M, average price $512.44Dec 2024: $1.8B, average price $401.38Mar 2025: $931.2M, average price $395.78Jun 2025: $380.5M, average price $410.05Sep 2025: $875.9M, average price $303.51Dec 2025: $472.6M, average price $335.63Mar 2026: $1.2B, average price $297.17Jun 2026: $235.8M, average price $342.01Sep 2026: $330.8M, average price $398.76
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 21, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ELV is in one of them and how their past ELV trades turned out.

ELV in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ELV in an article yet. Here's the latest on the wider market.

ELV Congress Trades

All congress trades →
Trades, 12 months
10
Buys
4
40%
Sells
6
60%
People
5
Last filed Aug 7
Who traded ELV · since 2021
Latest 5 filings of 105
$1K – $15KTraded Jul 20, 2026Filed Aug 7, 2026
$50K – $100KTraded May 18, 2026Filed Jul 25, 2026
$1K – $15KTraded Mar 27, 2026Filed Jul 21, 2026
$1K – $15KTraded May 15, 2026Filed Jun 9, 2026
$15K – $50KTraded Mar 18, 2026Filed May 14, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CASell$1K – $15KJul 20, 2026Aug 7, 202618 d
Markwayne MullinExecutive branchSell$50K – $100KMay 18, 2026Jul 25, 202668 d
Alan ArmstrongHouseBuy$1K – $15KMar 27, 2026Jul 21, 2026116 d
Ro KhannaD · CABuy$1K – $15KMay 15, 2026Jun 9, 202625 d
Donald J TrumpExecutive branchSell$15K – $50KMar 18, 2026May 14, 202657 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Elevance Health

Elevance Health is a health company based in Indianapolis, Indiana, that offers medical, pharmacy and behavioral health services. It sells managed care health plans to individuals, employers, Medicaid and Medicare programs, and the federal government, and it runs a pharmacy services business that serves its own plans and outside clients. Its Carelon businesses provide care management, analytics and related healthcare services to health plans and care providers.

Headquarters
Indianapolis, IN
Founded
1940